Cover Image
市場調查報告書

尿道癌:全球臨床實驗檢討

Urethral Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 301163
出版日期 內容資訊 英文 110 Pages
訂單完成後即時交付
價格
Back to Top
尿道癌:全球臨床實驗檢討 Urethral Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年04月30日 內容資訊: 英文 110 Pages
簡介

本報告提供尿道癌治療藥相關的臨床實驗調查分析,提供臨床實驗數及被實驗人數,階段及Phase別狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗上尿道癌的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:腫瘤科臨床實驗上尿道癌的比例

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與尿道癌治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Oncogenex Pharmaceuticals, Inc.
    • MethylGene Inc.
    • Merck & Co., Inc.
    • Eli Lilly and Company
    • Eisai
    • AstraZeneca PLC
    • Altor BioScience Corporation
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Southwest Oncology Group
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Eastern Cooperative Oncology Group
    • European Organization for Research and Treatment of Cancer
    • The Wales Cancer Trials Unit
    • Medical Research Council
    • Wake Forest University
    • University of Southern California

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2110CTIDB

GlobalData's clinical trial report, "Urethral Cancer Global Clinical Trials Review, H1, 2014" provides data on the Urethral Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urethral Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Urethral Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Urethral Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Urethral Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Urethral Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Urethral Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Urethral Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Oncogenex Pharmaceuticals, Inc.
      • Clinical Trial Overview of Oncogenex Pharmaceuticals, Inc.
      • MethylGene Inc.
      • Clinical Trial Overview of MethylGene Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Altor BioScience Corporation
      • Clinical Trial Overview of Altor BioScience Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Southwest Oncology Group
      • Clinical Trial Overview of Southwest Oncology Group
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • The Wales Cancer Trials Unit
      • Clinical Trial Overview of The Wales Cancer Trials Unit
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • University of Southern California
      • Clinical Trial Overview of University of Southern California
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Urethral Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Urethral Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Urethral Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Urethral Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Urethral Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Urethral Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Urethral Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Urethral Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Urethral Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncogenex Pharmaceuticals, Inc., 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc., 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Altor BioScience Corporation, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Wales Cancer Trials Unit, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Urethral Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2014*

List of Figures

  • Urethral Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Urethral Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Urethral Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Urethral Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Urethral Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Urethral Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Urethral Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Urethral Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Urethral Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology 1
Back to Top